SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-022599
Filing Date
2022-08-15
Accepted
2022-08-15 08:00:57
Documents
73
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1153771
2 ex31-1.htm EX-31.1 21250
3 ex31-2.htm EX-31.2 13086
4 ex32-1.htm EX-32.1 5705
  Complete submission text file 0001493152-22-022599.txt   5620079

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE clsn-20220630.xsd EX-101.SCH 48811
6 XBRL CALCULATION FILE clsn-20220630_cal.xml EX-101.CAL 65537
7 XBRL DEFINITION FILE clsn-20220630_def.xml EX-101.DEF 179814
8 XBRL LABEL FILE clsn-20220630_lab.xml EX-101.LAB 395521
9 XBRL PRESENTATION FILE clsn-20220630_pre.xml EX-101.PRE 293489
67 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 784226
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Filer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15911 | Film No.: 221162425
SIC: 2834 Pharmaceutical Preparations